Abstract:Skeletal muscle atrophy is a common feature of patients suffering with chronic infection and other systemic diseases, including acquired immunodeficiency syndrome, chronic kidney disease and cancer. Therefore, understanding the molecular basis of muscle loss is of importance. The majority of members of the forkhead box O (FoxO) family can induce skeletal muscle atrophy; however, the effect of FoxO6 on skeletal muscle is not completely understood. The present study investigated the role of FoxO6 in vitro and in vivo. Compared with the small interfering RNA (si)‑negative control (NC) group, C2C12 cell proliferation (Cell Counting Kit‑8 assay), myotube differentiation and myotube production were significantly decreased by FoxO6 knockdown, which was different from the known functions of other FoxO members. The immunofluorescence assay results demonstrated that si‑FoxO6 clearly downregulated the expression levels of myosin heavy chain (MyHC) in C2C12 myotubes compared with si‑NC. The western blotting results indicated that compared with the si‑NC group, FoxO6 knockdown induced C2C12 myotube atrophy by notably downregulating myoblast determination protein 1 (MyoD), mTOR and MyHC expression levels, and by markedly upregulating ubiquitin ligase (atrogin1) and muscle RING‑finger protein‑1 (MURF1) expression levels. Similarly, in an in vitro model of TNF‑α‑induced myotube atrophy, the western blotting results indicated that FoxO6 expression levels were decreased, whereas atrogin1, MURF1, FoxO1 and FoxO3a expression levels were increased compared with the control group. Therefore, the results indicated that, unlike FoxO1 or FoxO3a, FoxO6 maintained C2C12 myotubes and protected against atrophy. Consistent with the in vitro data, similar results were observed in vivo. Collectively, the results of the present study suggested that FoxO6 served a critical role in muscle cell metabolism in vitro and in vivo, and might serve as a promising therapeutic target for ameliorating skeletal muscle atrophy.

Regulation of Skeletal Muscle Development and Muscle Fiber-Type Transition by Six1

Stage-specific Effects of Notch Activation During Skeletal Myogenesis

Six1 regulates stem cell repair potential and self-renewal during skeletal muscle regeneration

Six1 and Six2 of the Sine Oculis Homeobox Subfamily Are Not Functionally Interchangeable in Mouse Nephron Formation

[New insights into adult muscle fiber-type diversity: involvement of Six homeoproteins]

LncRNA-Six1 Encodes a Micropeptide to Activate Six1 in Cis and Is Involved in Cell Proliferation and Muscle Growth.

Uncovering the Transcriptional Circuitry in Skeletal Muscle Regeneration

Advances on Functional Gene of Regulation of Skeletal Muscle Growth in Animals

Ectomesenchymal Six1 Controls Mandibular Skeleton Formation.

Identification of an evolutionarily conserved, functional noncoding element regulated by Six1 homeoprotein

ITGB6 inhibits the proliferation of porcine skeletal muscle satellite cells

Skeletal Muscle Satellite Cells Co-Opt the Tenogenic Gene to Instruct Regeneration

Identification of different myofiber types in pigs muscles and construction of regulatory networks

Mustn1 in Skeletal Muscle: A Novel Regulator?

Identification of a program of contractile protein gene expression initiated upon skeletal muscle differentiation

Cytoplasmatic Localization of Six1 in Male Testis and Spermatogonial Stem Cells

Transcriptional Regulatory Circuits Controlling Muscle Fiber Type Switching

Unique Sequence Repeats in the Α-Subunit of Protein Farnesyltransferases

Roles of Notch1 Signaling in Regulating Satellite Cell Fates Choices and Postnatal Skeletal Myogenesis

Role and mechanism underlying FoxO6 in skeletal muscle in vitro and in vivo

Developmental regulators drive DUX4 expression in facioscapulohumeral muscular dystrophy